Mar 17, 2025 12:00
TLSA - Tiziana Life Sciences Ltd. Common Shares
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
2.11 -0.09 (-4.27%) | --- | --- | --- | 0.0 (0.0%) | -0.1 (-4.72%) | -0.05 (-2.32%) | 0.0 (0.0%) |
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Category:
/stock/categories/na
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 100.0
- VWAP:
- 2.02
- RVol:
- 0.7302
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price increase 1m | 2.01 +0.02 (+1.01%) | Oct 16 14:32 |
1m | Price increase 1m | 2.06 +0.03 (+1.37%) | Oct 16 13:06 |
1m | Price increase 1m | 2.01 +0.03 (+1.52%) | Oct 16 12:45 |
1m | Price decrease 1m | 1.98 -0.02 (-1.0%) | Oct 16 12:44 |
1m | Price decrease 1m | 1.98 -0.05 (-2.61%) | Oct 16 12:24 |
Related News
Jan 23, 2025 20:00
Nov 01, 2024 17:00
Oct 31, 2024 02:29
Jun 28, 2024 15:01
Jun 26, 2024 11:00
Apr 25, 2024 14:00
Apr 19, 2024 11:00
Apr 18, 2024 11:00
Apr 11, 2024 11:00